Effects of Custom-Designed 3D-Printed and CAD-CAM Insoles on Individuals With Flexible Flatfoot
Launched by GÖZDE KESİKBAŞ · Jun 11, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how custom-made insoles, created with advanced 3D printing technology, can help people with flexible flat feet, also known as pes planus. The researchers want to see if these insoles can improve how pressure is distributed in the foot, help with foot pain, and enhance overall satisfaction when walking.
To participate in the trial, individuals must be between 18 and 55 years old and have been diagnosed with flexible flat feet. They should not have used custom orthotic insoles in the last six months and must be able to walk without any assistance. The study is not currently recruiting participants, but if selected, volunteers will undergo assessments to see how the insoles affect their foot health and comfort. It's important to note that people with certain medical conditions or previous foot surgeries may not be eligible for this trial.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals aged between 18 and 55 years
- • Diagnosed with flexible pes planus (flat feet)
- • No prior use of custom orthotic insoles within the past 6 months
- • Able to walk independently without assistive devices
- • Voluntarily agree to participate and provide informed consent
- Exclusion Criteria:
- • History of lower limb or foot surgery
- • Presence of neurological, rheumatologic, or musculoskeletal disorders affecting gait
- • Presence of severe foot deformities (e.g., rigid pes planus, cavus foot)
- • Use of medications that affect muscle or joint function
- • Pregnancy
About Gözde Kesi̇kbaş
Gözde Kesi̇kbaş is a dedicated clinical trial sponsor specializing in innovative research and development within the healthcare sector. With a commitment to advancing medical science and improving patient outcomes, Kesi̇kbaş leads rigorous clinical studies that adhere to the highest ethical and regulatory standards. The organization collaborates with leading researchers, institutions, and healthcare professionals to explore novel therapies and treatment modalities, ensuring comprehensive oversight and quality throughout the research process. By fostering a culture of collaboration and scientific integrity, Gözde Kesi̇kbaş aims to contribute significantly to the advancement of medical knowledge and the delivery of effective healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Samsun, , Turkey
Patients applied
Trial Officials
Nilgün Bek, PhD
Study Director
Lokman Hekim Üniversitesi
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported